-
Je něco špatně v tomto záznamu ?
Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has a Dramatic Effect on Viral Fitness
L. Eyer, H. Kondo, D. Zouharova, M. Hirano, JJ. Valdés, M. Muto, T. Kastl, S. Kobayashi, J. Haviernik, M. Igarashi, H. Kariwa, M. Vaculovicova, J. Cerny, R. Kizek, A. Kröger, S. Lienenklaus, M. Dejmek, R. Nencka, M. Palus, J. Salat, E. De Clercq,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-34238A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Freely Accessible Science Journals od 1967 do Před 6 měsíci
PubMed Central od 1967 do Před 6 měsíci
Europe PubMed Central od 1967 do Před 6 měsíci
Open Access Digital Library od 1967-02-01
Open Access Digital Library od 1967-02-01
Odkazy
PubMed
28814513
DOI
10.1128/jvi.01028-17
Knihovny.cz E-zdroje
- MeSH
- antivirové látky terapeutické užití MeSH
- mutace MeSH
- myši MeSH
- nukleosidy * analogy a deriváty terapeutické užití MeSH
- virová léková rezistence MeSH
- viry klíšťové encefalitidy * účinky léků MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Tick-borne encephalitis virus (TBEV) causes a severe and potentially fatal neuroinfection in humans. Despite its high medical relevance, no specific antiviral therapy is currently available. Here we demonstrate that treatment with a nucleoside analog, 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA), substantially improved disease outcomes, increased survival, and reduced signs of neuroinfection and viral titers in the brains of mice infected with a lethal dose of TBEV. To investigate the mechanism of action of 7-deaza-2'-CMA, two drug-resistant TBEV clones were generated and characterized. The two clones shared a signature amino acid substitution, S603T, in the viral NS5 RNA-dependent RNA polymerase (RdRp) domain. This mutation conferred resistance to various 2'-C-methylated nucleoside derivatives, but no cross-resistance was seen with other nucleoside analogs, such as 4'-C-azidocytidine and 2'-deoxy-2'-beta-hydroxy-4'-azidocytidine (RO-9187). All-atom molecular dynamics simulations revealed that the S603T RdRp mutant repels a water molecule that coordinates the position of a metal ion cofactor as 2'-C-methylated nucleoside analogs approach the active site. To investigate its phenotype, the S603T mutation was introduced into a recombinant TBEV strain (Oshima-IC) generated from an infectious cDNA clone and into a TBEV replicon that expresses a reporter luciferase gene (Oshima-REP-luc2A). The mutants were replication impaired, showing reduced growth and a small plaque size in mammalian cell culture and reduced levels of neuroinvasiveness and neurovirulence in rodent models. These results indicate that TBEV resistance to 2'-C-methylated nucleoside inhibitors is conferred by a single conservative mutation that causes a subtle atomic effect within the active site of the viral NS5 RdRp and is associated with strong attenuation of the virus.IMPORTANCE This study found that the nucleoside analog 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA) has high antiviral activity against tick-borne encephalitis virus (TBEV), a pathogen that causes severe human neuroinfections in large areas of Europe and Asia and for which there is currently no specific therapy. Treating mice infected with a lethal dose of TBEV with 7-deaza-2'-CMA resulted in significantly higher survival rates and reduced the severity of neurological signs of the disease. Thus, this compound shows promise for further development as an anti-TBEV drug. It is important to generate drug-resistant mutants to understand how the drug works and to develop guidelines for patient treatment. We generated TBEV mutants that were resistant not only to 7-deaza-2'-CMA but also to a broad range of other 2'-C-methylated antiviral medications. Our findings suggest that combination therapy may be used to improve treatment and reduce the emergence of drug-resistant viruses during nucleoside analog therapy for TBEV infection.
Central European Institute of Technology Brno University of Technology Brno Czech Republic
Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic
Department of Virology Veterinary Research Institute Brno Czech Republic
Institute for Laboratory Animal Science Hannover Medical School Hannover Germany
Institute for Medical Microbiology Otto von Guericke University Magdeburg Magdeburg Germany
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
Laboratory of Public Health Graduate School of Veterinary Medicine Hokkaido University Sapporo Japan
Rega Institute for Medical Research KU Leuven Leuven Belgium
Research Center for Zoonosis Control Hokkaido University Sapporo Japan
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22007426
- 003
- CZ-PrNML
- 005
- 20230815100715.0
- 007
- ta
- 008
- 220303s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/JVI.01028-17 $2 doi
- 035 __
- $a (PubMed)28814513
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Eyer, Luděk $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $7 xx0098551
- 245 10
- $a Escape of Tick-Borne Flavivirus from 2'-C-Methylated Nucleoside Antivirals Is Mediated by a Single Conservative Mutation in NS5 That Has a Dramatic Effect on Viral Fitness / $c L. Eyer, H. Kondo, D. Zouharova, M. Hirano, JJ. Valdés, M. Muto, T. Kastl, S. Kobayashi, J. Haviernik, M. Igarashi, H. Kariwa, M. Vaculovicova, J. Cerny, R. Kizek, A. Kröger, S. Lienenklaus, M. Dejmek, R. Nencka, M. Palus, J. Salat, E. De Clercq, K. Yoshii, D. Ruzek
- 520 9_
- $a Tick-borne encephalitis virus (TBEV) causes a severe and potentially fatal neuroinfection in humans. Despite its high medical relevance, no specific antiviral therapy is currently available. Here we demonstrate that treatment with a nucleoside analog, 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA), substantially improved disease outcomes, increased survival, and reduced signs of neuroinfection and viral titers in the brains of mice infected with a lethal dose of TBEV. To investigate the mechanism of action of 7-deaza-2'-CMA, two drug-resistant TBEV clones were generated and characterized. The two clones shared a signature amino acid substitution, S603T, in the viral NS5 RNA-dependent RNA polymerase (RdRp) domain. This mutation conferred resistance to various 2'-C-methylated nucleoside derivatives, but no cross-resistance was seen with other nucleoside analogs, such as 4'-C-azidocytidine and 2'-deoxy-2'-beta-hydroxy-4'-azidocytidine (RO-9187). All-atom molecular dynamics simulations revealed that the S603T RdRp mutant repels a water molecule that coordinates the position of a metal ion cofactor as 2'-C-methylated nucleoside analogs approach the active site. To investigate its phenotype, the S603T mutation was introduced into a recombinant TBEV strain (Oshima-IC) generated from an infectious cDNA clone and into a TBEV replicon that expresses a reporter luciferase gene (Oshima-REP-luc2A). The mutants were replication impaired, showing reduced growth and a small plaque size in mammalian cell culture and reduced levels of neuroinvasiveness and neurovirulence in rodent models. These results indicate that TBEV resistance to 2'-C-methylated nucleoside inhibitors is conferred by a single conservative mutation that causes a subtle atomic effect within the active site of the viral NS5 RdRp and is associated with strong attenuation of the virus.IMPORTANCE This study found that the nucleoside analog 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA) has high antiviral activity against tick-borne encephalitis virus (TBEV), a pathogen that causes severe human neuroinfections in large areas of Europe and Asia and for which there is currently no specific therapy. Treating mice infected with a lethal dose of TBEV with 7-deaza-2'-CMA resulted in significantly higher survival rates and reduced the severity of neurological signs of the disease. Thus, this compound shows promise for further development as an anti-TBEV drug. It is important to generate drug-resistant mutants to understand how the drug works and to develop guidelines for patient treatment. We generated TBEV mutants that were resistant not only to 7-deaza-2'-CMA but also to a broad range of other 2'-C-methylated antiviral medications. Our findings suggest that combination therapy may be used to improve treatment and reduce the emergence of drug-resistant viruses during nucleoside analog therapy for TBEV infection.
- 650 17
- $a viry klíšťové encefalitidy $x účinky léků $7 D004669 $2 czmesh
- 650 17
- $a nukleosidy $x analogy a deriváty $x terapeutické užití $7 D009705 $2 czmesh
- 650 _7
- $a virová léková rezistence $7 D024882 $2 czmesh
- 650 _7
- $a mutace $7 D009154 $2 czmesh
- 650 _7
- $a antivirové látky $x terapeutické užití $7 D000998 $2 czmesh
- 650 _7
- $a zvířata $7 D000818 $2 czmesh
- 650 _7
- $a myši $7 D051379 $2 czmesh
- 655 _2
- $a časopisecké články $7 D016428
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 700 1_
- $a Kondo, Hirofumi $u Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Zouharova, Darina $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic
- 700 1_
- $a Hirano, Minato $u Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Valdés, James J $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic
- 700 1_
- $a Muto, Memi $u Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Kastl, Tomas $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic
- 700 1_
- $a Kobayashi, Shintaro $u Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Haviernik, Jan $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic
- 700 1_
- $a Igarashi, Manabu $u Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Kariwa, Hiroaki $u Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Vaculovicova, Marketa $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic $u Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 700 1_
- $a Cerny, Jiri $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic
- 700 1_
- $a Kizek, Rene $u Central Laboratories, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
- 700 1_
- $a Kröger, Andrea $u Institute for Medical Microbiology, Otto von Guericke University Magdeburg, Magdeburg, Germany
- 700 1_
- $a Lienenklaus, Stefan $u Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany
- 700 1_
- $a Dejmek, Milan $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Nencka, Radim $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Palus, Martin $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic
- 700 1_
- $a Salat, Jiri $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic
- 700 1_
- $a De Clercq, Erik $u Rega Institute for Medical Research, KU Leuven, Leuven, Belgium
- 700 1_
- $a Yoshii, Kentaro $u Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
- 700 1_
- $a Růžek, Daniel, $d 1981- $u Department of Virology, Veterinary Research Institute, Brno, Czech Republic ruzekd@paru.cas.cz $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $7 stk2008441707
- 773 0_
- $w MED00003048 $t Journal of virology $x 1098-5514 $g Roč. 91, č. 21 (2017)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28814513 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220303 $b ABA008
- 991 __
- $a 20230815100711 $b ABA008
- 999 __
- $a kom $b bmc $g 1766120 $s 1158615
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 91 $c 21 $e 20171013 $i 1098-5514 $m Journal of virology $n J Virol $x MED00003048
- GRA __
- $a NV16-34238A $p MZ0
- LZP __
- $c NLK120 $d 20230111 $a 2021-granty